Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Classical hematology 1

Conditions

Leukemia 2Preleukemia 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1Cytopenia 1Bone Marrow Diseases 1Anemia 1

Interventions

Cytarabine 184Cyclophosphamide 176fludarabine 146Azacitidine 121venetoclax 115fludarabine phosphate 104Rituximab 80Decitabine 74Filgrastim 58Specimen Handling 55Etoposide 55Lenalidomide 47Biopsy 45Dexamethasone 41Methotrexate 40Bortezomib 40Mitoxantrone 39Granulocyte Colony-Stimulating Factor 39Daunorubicin 39Vincristine 37Melphalan 36ibrutinib 35Tacrolimus 35Dasatinib 34Whole-Body Irradiation 32Clofarabine 32Peripheral Blood Stem Cell Transplantation 31Mycophenolic Acid 31Injections 31Idarubicin 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Sertraline × Other hematologic neoplasm × Clear all
NCT02891278 2023-04-12

Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML

Columbia University

Phase 1 Completed
6 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT02452983 2022-06-02

SS1

Baylor College of Medicine

Phase 1 Terminated
14 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Anemia, Bone Marrow Diseases, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Preleukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡